James E. Wagner Cultivation Announces a Rating of Compliant After Health Canada Inspections

James E. Wagner Cultivation Corporation (“

JWC

” or the “

Corporation

”) (TSX VENTURE: JWCA; OTCQX: JWCAF), receives a “Compliant” rating from Health Canada for both production sites located at 855 Trillium Drive, Kitchener and 530 Manitou Drive, Kitchener.

Establishing effective Standard Operating Procedures and monitoring compliance activities are key elements of JWC’s commitment to operational excellence. On-site inspections were conducted by Health Canada in late October and early November of 2019 at both the Manitou and Trillium Drive locations.

In receiving a rating of “Compliant” from Health Canada, clients can be assured that JWC is observing and upholding rules and regulations to meet the operational requirements established by Health Canada. The Corporation is also delivering on the required best production practices to safeguard client health.

These requirements, established by the Cannabis Act and its Regulations, define the framework for legal access to cannabis and a framework for controls and regulations of production, processing, distribution and sale of cannabis.

“Our Compliance Team is dedicated to understanding the law and our Corporate obligations with respect to all regulated activities,” commented Nathan Woodworth, JWC President and CEO. “It’s one of the most important aspects of our business. By having accurate measures and detailed processes in place, we have the ability to not only monitor and achieve operational excellence, we can be assured that we are in compliance with the Cannabis Act and its Regulations.”

JWC places a high priority on operating first-rate production facilities and, as part of the corporate culture, is relentlessly focused on establishing standards and procedures which allow it to retain a status of being compliant with Health Canada requirements.

Having established its rating of being compliant, JWC is better able to focus on maintaining and enhancing its production operations with a continuing over-arching goal of profitability. This rating from Health Canada ensures that we stay firmly on track in achieving our goals.

About James E. Wagner Cultivation Corporation

James E. Wagner Cultivation Corporation’s wholly owned subsidiary is a Licensed Producer under the Cannabis Regulations, formerly the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis using an advanced and proprietary aeroponic platform named GrowthSTORM™. JWC began as a collective of patients and growers under the Marihuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC is a family-founded company with deep roots planted in the local community. JWC’s operations are based in Kitchener, Ontario. Learn more at www.jwc.ca.

Notice regarding forward-looking statements:

This press release contains statements including forward-looking information for purposes of applicable securities laws (“forward-looking statements”) about JWC and its business and operations which include, among other things, statements regarding the ability to retain a rating of compliance with its production methods, and implementation of enhancements to its operations on a consistently high standard of compliance. The forward-looking information contained in this news release are based on the Corporation’s current internal expectations, estimates, projections, assumptions, and beliefs and views of future events which management believes to be reasonable in the circumstances, including expectations and assumptions regarding: general economic conditions, the expected timing and cost of expanding the Corporation’s production capacity, the internal opportunities, the development of new products and product formats, the Corporation’s ability to retain key personnel, the Corporation’s ability to continue investing in its infrastructure to support growth, the impact of competition, trends in the Canadian cannabis industry and changes in laws, rules, and events, performance or results, and will not necessarily be accurate indications as to whether, or the times at which, such events, performance or results will occur or be achieved. The forward-looking statements can be identified by the use of such words as “anticipated”, “will”, “expected”, “approximately”, “may”, “could”, “would” or similar words and phrases. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those implied in the forward-looking statements. For example, risks include risks regarding the cannabis industry, economic factors, the equity markets generally, funding and grant related risks and risks associated with growth and competition as well as the risks identified in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com. Although JWC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and are based on current assumptions which management believes to be reasonable. The Corporation disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Company ContactNathan Woodworth, President & CEO of JWC(519) 594-0144 x [e-mail]

Investor RelationsJonathan LeuchsCMA(949) 432-7758 [e-mail]